Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Reiser

Showing results (51-60 of 242) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|March 28, 2014
Abatacept in B7-1-positive proteinuric kidney diseaseNada Alachkar, Naima Carter-Monroe, Jochen Reiser
Advances in Chronic Kidney Disease|August 30, 2014
Permeability factors in focal and segmental glomerulosclerosisJochen Reiser, Cynthia C Nast, Nada Alachkar
The New England Journal of Medicine|May 28, 2020
Soluble Urokinase Receptor and Acute Kidney Injury. ReplySalim S Hayek, David E Leaf, Jochen Reiser
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2013
Is there clinical value in measuring suPAR levels in FSGS?Sanja Sever, Howard Trachtman, Changli Wei, et al.
The New England Journal of Medicine|March 11, 2016
Soluble Urokinase Receptor and Chronic Kidney DiseaseSalim S Hayek, Arshed A Quyyumi, Jochen Reiser
Journal of the American Society of Nephrology : JASN|January 5, 2000
The glomerular slit diaphragm is a modified adherens junctionJochen Reiser, Wilhelm Kriz, Matthias Kretzler, et al.
Kidney International|May 16, 2012
Podocyte GTPases regulate kidney filter dynamicsAndreas D Kistler, Mehmet M Altintas, Jochen Reiser
Frontiers in Medicine|October 25, 2021
suPAR, a Circulating Kidney Disease FactorChangli Wei, Ryan Spear, Eunsil Hahm, et al.
Advances in Chronic Kidney Disease|April 4, 2006
The genetic basis of human glomerular diseaseClemens C Möller, Martin R Pollak, Jochen Reiser
International Journal of Nephrology|September 27, 2018
Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple MyelomaBenjamin A Derman, Jochen Reiser, Sanjib Basu, et al.
Pageof 25

Showing results (51-60 of 242) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|March 28, 2014
Abatacept in B7-1-positive proteinuric kidney diseaseNada Alachkar, Naima Carter-Monroe, Jochen Reiser
Advances in Chronic Kidney Disease|August 30, 2014
Permeability factors in focal and segmental glomerulosclerosisJochen Reiser, Cynthia C Nast, Nada Alachkar
The New England Journal of Medicine|May 28, 2020
Soluble Urokinase Receptor and Acute Kidney Injury. ReplySalim S Hayek, David E Leaf, Jochen Reiser
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2013
Is there clinical value in measuring suPAR levels in FSGS?Sanja Sever, Howard Trachtman, Changli Wei, et al.
The New England Journal of Medicine|March 11, 2016
Soluble Urokinase Receptor and Chronic Kidney DiseaseSalim S Hayek, Arshed A Quyyumi, Jochen Reiser
Journal of the American Society of Nephrology : JASN|January 5, 2000
The glomerular slit diaphragm is a modified adherens junctionJochen Reiser, Wilhelm Kriz, Matthias Kretzler, et al.
Kidney International|May 16, 2012
Podocyte GTPases regulate kidney filter dynamicsAndreas D Kistler, Mehmet M Altintas, Jochen Reiser
Frontiers in Medicine|October 25, 2021
suPAR, a Circulating Kidney Disease FactorChangli Wei, Ryan Spear, Eunsil Hahm, et al.
Advances in Chronic Kidney Disease|April 4, 2006
The genetic basis of human glomerular diseaseClemens C Möller, Martin R Pollak, Jochen Reiser
International Journal of Nephrology|September 27, 2018
Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple MyelomaBenjamin A Derman, Jochen Reiser, Sanjib Basu, et al.
Pageof 25